Filana Therapeutics (FLNA) Net Margin (2010 - 2026)
Filana Therapeutics' Net Margin was 93.68% in Q4 2013, up 166.37 percentage points from -72.69% a year earlier and up 132.59 percentage points from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) Net Margin (2010 - 2026) Analysis & Trends
For FY2013, Net Margin at Filana Therapeutics came in at 76.71%, up 108.36 percentage points from FY2012.
- Net Margin shows a four-year change of +93.57 percentage points (FY2009 to FY2013).
- In earlier years, Net Margin was -31.64% in FY2012 (-8.89 pp), -22.75% in FY2011 (+48.77 pp), -71.53% in FY2010 (-54.67 pp) and -16.86% in FY2009.
- The Q4 2013 figure marks the highest quarterly Net Margin in data going back to Q2 2010.
- Compared with a year earlier, Net Margin was higher in four of the last eight quarters, with an average year-over-year change of +14.05 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q4 2013 (a gain of 166.37 percentage points); the worst was Q4 2012 (a drop of 58.46 percentage points).
- Per Business Quant data, FLNA's Net Margin in the three quarters before Q4 2013 was -38.92% (Q3 2013), -15.36% (Q2 2013) and -20.84% (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | Filana Therapeutics | 32.11 Mn | -338.73 Mn | - | -1,151.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,151.67% |
| Mar 31, 2026 | -1,309.38% |
| Dec 31, 2025 | -1,287.37% |
| Sep 30, 2025 | -926.05% |
| Jun 30, 2025 | -3,642.83% |
| Mar 31, 2025 | -1,850.04% |
| Dec 31, 2024 | -1,533.17% |
| Sep 30, 2024 | -1,067.34% |
| Jun 30, 2024 | 265.76% |
| Mar 31, 2024 | -1,055.69% |
| Dec 31, 2023 | -1,324.83% |
| Sep 30, 2023 | -1,279.35% |
| Jun 30, 2023 | -1,200.00% |
| Mar 31, 2023 | -1,183.37% |
| Dec 31, 2022 | -1,231.27% |
| Sep 30, 2022 | -2,307.18% |
| Dec 31, 2013 | 93.68% |
| Sep 30, 2013 | -38.92% |
| Jun 30, 2013 | -15.36% |
| Mar 31, 2013 | -20.84% |
API Access
Filana Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();